Cited by 1,193Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Open access
Arnett, Donna K., Blumenthal, Roger S., Albert, Michelle A., Buroker, Andrew B., Goldberger, Zachary D., Hahn, Ellen J., Himmelfarb, Cheryl Dennison, Khera, Amit +10 more·2019·Journal of the American College of Cardiology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.03.009

Cites

281 of 281 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • According to the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, there is likely no lower limit on the amount of moderate-to-vigorous physical activity at which benefits for ASCVD risk start to accrue.

    “According to the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, there is likely no lower limit on the amount of moderate-to-vigorous physical activity at which benefits for ASCVD risk start to accrue, and effort should be made to promote achievement of the minimum recommended amount of physical activity (44).”

    From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [44]

    The Exercise and Physical Activity recommendations (page not provided) say that some moderate- or vigorous-intensity activity below the recommended minimum can reduce ASCVD risk, and recommend aiming for at least 150 minutes of moderate or 75 minutes of vigorous activity weekly. They do not establish that there is no lower limit at which benefits begin. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

5 of the 286 references couldn’t be matched to a known paper.

Research works printed but not linked: 14

  1. del Rincón ID, Williams K, Stern MP, High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737– 45. 11762933
  2. LeBlanc EL, Patnode CD, Webber EM, Draft evidence review for weight loss to prevent obesity-related morbidity and mortality in adults: behavioral interventions Kaiser Permanente Research Affiliates Evidence-based Practice Center, Kaiser Permanente Center for Health Research: Portland, OR; 2018. AHRQ Publication No. 18–05239-EF-1. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/draft-evidence-review/obesity-in-adults-interventions1. Accessed January 5, 2019.
  3. Chou R, Dana T, Blazina I, Statin use for the prevention of cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Report No. 14–05206-EF-2 Rockville, MD: U.S. Agency for Healthcare Research and Quality, 2016. Available at: http://www.ncbi.nlm.nih.gov/books/NBK396415. Accessed January 5, 2019. 27905702
  4. Ridker PM, Danielson E, Fonseca FAH, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195– 207. 18997196
  5. Mortensen MB, Fuster V, Muntendam P, A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study. J Am Coll Cardiol 2016; 68: 881– 91. 27561760
  6. Nasir K, Bittencourt MS, Blaha MJ, Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2015; 66: 1657– 68. 26449135
  7. Yano Y, O’Donnell CJ, Kuller L, Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol 2017; 2: 986– 94. 28746709 PMC5710171
  8. Budoff MJ, Young R, Burke G, Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J 2018; 39: 2401– 8. 29688297 PMC6030975
  9. Whelton PK, Carey RM, Aronow WS, 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71: e127– 248. 29146535
  10. Sacks FM, Svetkey LP, Vollmer WM, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3– 10. 11136953
  11. Bress AP, Bellows BK, King JB, Cost-effectiveness of intensive versus standard blood-pressure control. N Engl J Med. 2017; 377: 745– 55. 28834469 PMC5708850
  12. [3]Selph S, Dana T, Bougatsos C, Screening for abnormal glucose and type 2 diabetes mellitus: a systematic review to update the 2008 U.S. Preventive Services Task Force Recommendation. Report No. 13–05190EF-1 Rockville, MD: U.S. Agency for Healthcare Research and Quality, 2015. Availableat: http://www.ncbi.nlm.nih.gov/books/NBK293871. Accessed January 5, 2019. 25973510
  13. [4]Patnode CD, Henderson JT, Thompson JH, Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive ServicesTask Force. Ann Intern Med 2015; 163: 608– 21. 26389650
  14. [5]Guirguis-Blake JM, Evans CV, Senger CA, Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2016; 164: 804– 13. 27064410

Cited by

Sorted by citations

Authors
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2019-09
Volume
74
Issue
10
Pages
1376-1414
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2984766121
Cited by
1,193
References
286
Citations by year
2026: 87 · 2025: 140 · 2024: 131 · 2023: 167 · 2022: 191 · 2021: 207 · 2020: 191 · 2019: 79
FWCI
153.80
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • American Heart Association (17SDG33630113)
  • National Institutes of Health (KL2TR001882)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
primary prevention, cardiovascular disease, cardiovascular risk factors, cardiovascular disease prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review